Home / Pharmaceuticals / Global Laxatives Market By Drugs (Senna, Bisacodyl, Docusate, Polyethylene Glycol 3350, Psyllium, Methylcellulose, Pipeline Drug Analysis: BLI 801, Others), Prescription (Prescribed, Over the Counter Drugs) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Global Laxatives Market By Drugs (Senna, Bisacodyl, Docusate, Polyethylene Glycol 3350, Psyllium, Methylcellulose, Pipeline Drug Analysis: BLI 801, Others), Prescription (Prescribed, Over the Counter Drugs) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Published: Mar 2016 | Report Code: 57740-03-16

This report on global laxatives market studies various drugs used for treatment and management of constipation. The National Institute of Diabetes and Digestive and Kidney Diseases, U.S. defines constipation as 'condition in which you have fewer than three bowel movements a week, or hard, dry and small bowel movements that are painful or difficult to pass'.
For the purpose of this study, the various drugs segments studied include senna, bisacodyl, docusate, polyethylene glycol, psyllium, methylcellulose, and others. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective CAGRs for the period 2016 to 2022, considering 2015 as the base year.

On terms of prescription type, the global laxatives market is studied for prescribed laxatives and OTC laxatives segments. The prescribed laxatives segment is further categorized into branded prescribed and generic prescribed laxatives. Market size and forecast for these segments during 2013 to 2022 and their compounded annual growth rates for the period 2016 to 2022 are provided in this report.

The geographic segmentation of the global laxatives market is performed for the regions North America, Europe, Asia Pacific and Rest of the World markets. The former three regional markets further study two top national markets. Their elucidation is as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific

The Rest of the World region is studied for Middle East and North Africa, and Latin America markets. The U.S. market covers the drug type and prescription type segmentation in line with the global market.

In terms of qualitative analysis, informative sets such as market dynamics: drivers, challenges and opportunities; and attractive investment proposition. This study concludes with profiling of the major market players active in development, manufacture and sale of laxative drugs in the international markets.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Methodology

Chapter 2 Executive Summary
2.1 Global and U.S. Laxatives Market Portaiture
2.2 Laxatives Market, by Drugs, 2015 (USD Mn)
2.3 Laxatives Market, by Prescription Type, 2015 (USD Mn)
2.4 Laxatives Market Share, by Geography, 2015 (Value %)

Chapter 3 Laxatives Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.1.1 Potential Patient Population
3.1.2 Prevalent Treatment Options
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Lifestyle Trends Increase the Risk of Constipation thus Consumption of Laxatives
3.2.1.2 Higher Prevalence of Constipation in Geriatric Population
3.2.2 Challenges
3.2.2.1 Demographic Reservations to Impact the Market
3.2.3 Opportunities
3.2.3.1 Emerging Markets Present Lucrative Opportunity for Growth
3.3 Attractive Investment Proposition
3.4 Competitive Analysis
3.4.1 Fractal Map Investigation

Chapter 4 Global Laxatives Market Analysis, by Drugs
4.1 Preface
4.2 Senna
4.3 Bisacodyl
4.4 Docusate
4.5 Polyethylene Glycol 3350
4.6 Psyllium
4.7 Methylcellulose
4.8 Others
4.9 Pipeline Drug Analysis: BLI 801

Chapter 5 Global Laxatives Market Analysis, By Prescription Type
5.1 Preface
5.2 Prescribed Drugs
5.3 Over the Counter Drugs

Chapter 6 Global Laxatives Market Analysis, By Geography
6.1 Preface
6.2 North America
6.2.1 United States
6.2.2 Canada
6.3 Europe
6.3.1 U.K.
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 China
6.4.2 Japan
6.4.3 Rest of Asia Pacific
6.5 Rest of the World (RoW)

Chapter 7 Company Profiles
7.1 Bayer AG
7.1.1 Company Details (Contact Details, Revenue, Key Competitors, Distribution Partners)
7.1.2 Product Portfolio
7.2 Boehringer Ingelheim Pharmaceuticals, Inc.
7.2.1 Company Details (Contact Details, Revenue, Key Competitors)
7.2.2 Product Portfolio
7.2.3 Recent Developments
7.3 GlaxoSmithKline Consumer Healthcare, L.P.
7.3.1 Company Details (Contact Details, Revenue, Key Competitors, Financial Health and Budget Allocation)
7.3.2 Product Portfolio
7.3.3 Key Developments
7.4 Procter & Gamble Company
7.4.1 Company Details (Contact Details, Revenue, Key Competitors, Financial Health and Budget Allocation)
7.4.2 Product Portfolio
7.4.3 Key Developments
7.5 Purdue Pharma
7.5.1 Company Details (Contact Details, Revenue, Key Competitors, Distribution Partners)
7.5.2 Company Overview (Business Overview, Product Portfolio)
7.5.3 Product Portfolio
7.5.4 Recent Developments
7.6 Sucampo Pharmaceuticals, Inc.
7.6.1 Company Details (Contact Details, Revenue, Key Competitors)
7.6.2 Product Portfolio
7.6.3 Recent Developments

List of Tables

TABLE 1 Global Laxatives Market Revenue, by Drugs, 2013 – 2022 (USD Mn)
TABLE 2 Global Laxatives Market Revenue, by Prescription Type, 2013 – 2022 (USD Mn)
TABLE 3 Global Prescribed Laxatives Market Revenue, (Branded and Generic Drugs), 2013 – 2022 (USD Mn)
TABLE 4 Global Laxatives Market Revenue, by Geography, 2013 – 2022 (USD Mn)
TABLE 5 North America Laxatives Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 6 U.S. Laxatives Market Revenue, by Drugs, 2013 – 2022 (USD Mn)
TABLE 7 U.S. Laxatives Market Revenue, by Prescription Type, 2013 – 2022 (USD Mn)
TABLE 8 U.S. Prescription Laxatives Market Revenue, (Branded and Generic Drugs) , 2013 – 2022 (USD Mn)
TABLE 9 Europe Laxatives Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 10 Asia Pacific Laxatives Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 11 Rest of the World Laxatives Market Revenue, by Regions, 2013 – 2022 (USD Mn)

List of Figures

FIG. 1 Laxatives Market, by Drugs, 2015 (USD Mn)
FIG. 2 Laxatives Market, by Prescription Type, 2015 (USD Mn)
FIG. 3 Laxatives Market Share, by Geography, 2015 (Value %)
FIG. 4 Median Prevalence of Constipation Across Various Geographies
FIG. 5 Attractive Investment Proposition, Breast Biopsy Devices Market, 2015
FIG. 6 Fractal Map Investigation, Global Laxatives Market, by Key Players
FIG. 7 Global Senna Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 8 Global Bisacodyl Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 9 Global Docusate Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 10 Global Polyethylene Glycol 3350 Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 11 Global Psyllium Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 12 Global Methylcellulose Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 13 Global Other Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 14 Global Over the Counter Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 15 Canada Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 16 U.K. Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 17 Germany Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 18 Rest of Europe Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 19 China Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 20 Japan Laxatives Market Revenue, 2013 – 2022 (USD Mn)
FIG. 21 Rest of Asia Pacific Laxatives Market Revenue, 2013 – 2022 (USD Mn)

Drug Type Segmentation Investigation
This study analyses the global laxatives market for senna, bisacodyl, docusate, polyethylene glycon 3350, psyllium, methylcellulose and others. Among these drug types, psyllium laxatives segment leads in terms of market revenue share and is closely followed by docusate segment. 

Laxatives Market

 

Psyllium, also called as isphagula or isapgol is among the most widely used laxatives due to their age-old usage and cost-effectiveness. US is the largest importer of psyllium whereas South-east Asia is the largest producer. Offered benefits such as ease of consumption, safety, and price effectiveness are the prime factors that contribute to the perpetually high demand for psyllium in the global market. On the other hand, withdrawn effectiveness in long-term use and restricted efficacy in treating more severe forms of constipation may hold back the market growth of this segment.

On the other hand, osmotic laxative: Polyethylene Glycol 3350 is the fastest progressing laxative segment. It is among the highest selling OTC laxative in the North America and other developed markets. MiraLAX by Schering-Plough (through licensing agreement with Braintree Laboratories) is the biggest brand name for polyethylene glycol laxatives and is claimed to be the most successful Rx to OTC switch in the laxatives category.

Geography Segmentation Analysis
North America is estimated to be the largest market for laxatives on the global front. Large consumption of pharmaceutical drugs in the US, better and well established reimbursement system and widespread awareness about disease management are the major characteristics of North America market.

Global Laxatives Market

North America (U.S. and Canada), Europe (U.K., Germany and Rest of Europe), Asia Pacific (Japan, China and Rest of Asia Pacific) and Rest of the World (Middle East and North Africa, Latin America and Rest) cumulatively make the global laxatives market. United States is the largest national market for laxatives worldwide.

Perpetually increasing pool of geriatric population and their higher susceptibility towards constipation, and growing trend of transfer to palliative care and nursing homes are the prime features on the U.S. market. Both prescribed and OTC laxatives are greatly consumed in the U.S., with a higher preference for allopathic drugs than the herbal and eastern alternatives. As the patient pool augments, the demand for breakthrough, advanced and more effective laxatives is expected.

Prescription Type Segmentation Investigation
The laxatives market is categorized into prescribed drugs and OTC drugs segments. The prescribed drugs segment is further categorized into branded prescribed and generic prescribed drugs markets.

Global Laxatives Market

OTC sales form a major portion of the overall laxatives revenue. Generic products such as senna drugs, psyllium derived laxatives, magnesium hydroxide products are viewed as among the safest OTC laxatives and stayed in the market for a long time. Other drugs segments such as docusate and bisacodyl also observe similar trends. Instances such as episodes of severe constipation and self reporting to prolonged constipation lead to opting for prescribed laxatives.

The demand for prescription laxatives is higher in the developed markets of North America and Europe. Whereas OTC drugs and home remedies for constipation treatment form a trend in Asia Pacific and Rest of the World regions.

Improving awareness about the long term effects of constipation on life and overall wellbeing however is influencing the potential patient population to opt for clinical assistance. Moreover, introduction of breakthrough drugs in the market will further augment the demand for prescribed laxatives in the market.

Hismation: Laxatives Market
The National Institute of Diabetes and Digestive and Kidney Diseases, US defines constipation as a ‘condition in which you have fewer than three bowel movements a week, or hard, dry and small bowel movements that are painful or difficult to pass’. Constipation is broadly classified into two categories, namely functional and secondary constipation.

Functional constipation is also categorized into normal transit, slow transit and outlet constipation. Secondary constipation is an outcome of external medical conditions and/or as an effect of other medications. Such factors include, less dietary fiber intake, change in day-to-day routine, effect of medications such as opioids, other pain relievers, antidepressants and others.

Constipation is among the most frequently occurring gastrointestinal conditions observed worldwide. The prevalence of the condition varies between 0.7% to 79% (at a median of 16%), where it is high among geriatric population, particularly those under palliative care. The prevalence of constipation symptoms is also higher among women. The median province of constipation among children is 12%. Since constipation usually occurs due to external factors, it is deemed as a conditional disorder than a disease.

Moreover, due to its commonality in the global population, only a minority of patients tend to seek professional medical care for treatment. This has contributed to difficulty in exa ct estimation of prevalence of constipation. Due to the various reporting criteria for defining constipation and variance in the age groups investigated, direct statistical comparison cannot be made between countries, continents or regions. However, the prevalence of the condition is observed to be higher in non-Caucasian population.

Global Laxatives Market

The base-line treatment for constipation includes change in dietary habits, lifestyle alteration, and medications. Laxatives are used as primary medications for treating constipation. Bulk forming laxatives, osmotic laxatives, lubricants, stimulant laxatives and others are the laxative types for medically treating constipation. Senna, Bisacodyl, Docusate, Polyethylene Glycol 3350, Psyllium, and Methylcellulose are the major laxative drug types.

Based on the available treatment options, constipation and respective treatments is categorised as follows:

Laxatives Market

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients